↓ Skip to main content
What is this page? Embed badge

Resistance to Targeted Therapies in Lymphomas

Overview of attention for book
Cover of 'Resistance to Targeted Therapies in Lymphomas'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Mechanisms of Glucocorticoid Response and Resistance in Lymphoid Malignancies
  3. Altmetric Badge
    Chapter 2 Resistance to Monoclonal Antibody Therapeutics in Lymphoma
  4. Altmetric Badge
    Chapter 3 Resistance to Antibody-Drug Conjugate
  5. Altmetric Badge
    Chapter 4 Resistance to Proteasome Inhibitor Therapy in Non-Hodgkin Lymphoma
  6. Altmetric Badge
    Chapter 5 Resistance to Histone Deacetylase Inhibitors in the Treatment of Lymphoma
  7. Altmetric Badge
    Chapter 6 Resistance to Bruton’s Tyrosine Kinase Signaling Pathway Targeted Therapies
  8. Altmetric Badge
    Chapter 7 Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
  9. Altmetric Badge
    Chapter 8 Resistance to Bispecific T-Cell Engagers and Bispecific Antibodies
  10. Altmetric Badge
    Chapter 9 Resistance to Chimeric Antigen Receptor T-Cell Therapy
Attention for Chapter 7: Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
Altmetric Badge
Summary
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Resistance to Checkpoint Blockade Inhibitors and Immunomodulatory Drugs
Chapter number 7
Book title
Resistance to Targeted Therapies in Lymphomas
Published by
Springer, Cham, January 2019
DOI 10.1007/978-3-030-24424-8_7
Book ISBNs
978-3-03-024423-1, 978-3-03-024424-8
Authors

Anthony N. Audino, Mitchell S. Cairo

View on publisher site

This page is provided by Altmetric.